Finanzen von Stepan Co (SCL)SCLStepan Co

Stepan Co (SCL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Surfactants, accounting for 75.0% of total sales, equivalent to $453.69M. Other significant revenue streams include Polymers and Specialty Products. Understanding this composition is critical for investors evaluating how SCL navigates market cycles within the Specialty Chemicals industry.

Evaluating the bottom line, Stepan Co maintains a gross margin of 14.61%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.20%, while the net margin is 3.35%. These profitability ratios, combined with a Return on Equity (ROE) of -0.22%, provide a clear picture of how effectively SCL converts its operational activities into shareholder value.

In the context of the broader market, SCL competes directly with industry leaders such as REX and ECVT. With a market capitalization of $1.41B, it holds a significant position in the sector. When comparing efficiency, SCL's gross margin of 14.61% stands against REX's 28.52% and ECVT's 19.09%. Such benchmarking helps identify whether Stepan Co is trading at a premium or discount relative to its financial performance.

Stepan Co has shown solid revenue growth, with Q2 2026 revenue at $684.11 million, a 15% increase year-over-year. The gross margin improved to 14.61% in Q2 2026, up from 10.73% in Q1 2026, indicating better cost management and operational efficiency.